Variant Bio

Exceptional traits among us.

Seattle, United States · Founded 2018 · $171.0M raised

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$171.0M
Last Round
$50.0M Corporate RoundJan 2025
Rounds
3

About

Variant Bio studies genetic variants of health outliers to identify drug targets. Founded 2018 in Seattle. Partnership with Novo Nordisk worth up to $50M.

Summary

Variant Bio is a Life Sciences company based in Seattle, United States, founded in 2018. It has raised $171.0M in total across 3 rounds, most recently a $50.0M Corporate Round round in Jan 2025. Investors include Novo Nordisk, Lux Capital and SoftBank.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundNovo Nordisk Strategic PartnershipJan 2025
$50.0M

Sign up to see all 3 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Variant Bio on Indexed.vc
<a href="https://indexed.vc/companies/variant-bio"><img src="https://indexed.vc/api/badge/company/variant-bio" alt="Variant Bio on Indexed.vc" width="260" height="76" /></a>